Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

ClinicalTrials.gov ID: NCT05832229

Public ClinicalTrials.gov record NCT05832229. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 20, 2026, 8:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Liver Cirrhosis Network (LCN) Rosuvastatin Efficacy and Safety for Cirrhosis in the United States (RESCU): A Double-Blind Randomized, Placebo-Controlled Phase 2 Study

Study identification

NCT ID: NCT05832229
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Enrollment: 256 participants

Conditions and interventions

Conditions

Interventions

Rosuvastatin Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 75 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 6, 2023
Primary completion: Aug 30, 2029
Completion: Aug 30, 2029
Last update posted: Jan 12, 2026

2023 – 2029

United States locations

U.S. sites: 13
U.S. states: 8
U.S. cities: 10

Facility	City	State	ZIP	Site status
University of California San Diego NAFLD Research Center	La Jolla	California	92035	Recruiting
Keck Medical Center of USC	Los Angeles	California	90033	Recruiting
LAC + USC Medical Center	Los Angeles	California	90033	Recruiting
UCSF/Zuckerberg San Francisco General Hospital and Trauma Center	San Francisco	California	94110	Recruiting
UCSF Medical Center	San Francisco	California	94143	Recruiting
University of Miami Health System	Miami	Florida	33122	Recruiting
University of Michigan	Ann Arbor	Michigan	48109	Recruiting
Mayo Clinic	Rochester	Minnesota	55901	Recruiting
New York Presbyterian/Weill Cornell	New York	New York	10021	Recruiting
Columbia University Iriving School of Medicine	New York	New York	10031	Recruiting
Duke Liver Center	Durham	North Carolina	27710	Recruiting
Cleveland Clinic	Cleveland	Ohio	44192	Recruiting
Virginia Commonwealth University	Richmond	Virginia	23298	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05832229, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 12, 2026 · Synced May 20, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05832229 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →